Left ventricular hypertrophy and silent ischaemia: a pilot study to examine the relationship in hypertensive patients

Journal of Human Hypertension

Volumn 15, Issue , 2001, Pages S75-S77

  O’Brien, Eoin ^a   Gribbin, C ^a   Stanton, A ^b   Atkins, N ^a   Lyons, S ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Combined ambulatory blood pressure; Ecg monitor; Left ventricular hypertrophy; Silent ischaemia; Transient ischaemia

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIA; MALE; OUTCOMES RESEARCH; PILOT STUDY; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE MONITORING, AMBULATORY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIAL ISCHEMIA; PILOT PROJECTS;

EID: 0034794038     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001090     Document Type: Article

References (14)

1. De-Leeuw PW et al. Hypertension and the development of heart failure. J Cardiovasc Pharmacol 1998; 32 (Suppl 1): S9-S15.
2. Opie LH et al. The multifarious spectrum of ischemic left ventricular dysfunction: relevance of new ischemic syndromes. J Mol Cell Cardiol 1996; 28: 2403-2414.
3. Conlon PJ et al. Incidence and long-term significance of transient ST segment deviation in hemodialysis patients. Clin Nephrol 1998; 49: 236-239.
4. Kovacevic DV et al. Asymptomatic myocardial ischemia before and after surgical revascularisation in patients with multivessel occlusive coronary disease. Med Pregl 1998; 51: 73-75.
5. Erne P et al. Antiischemic therapy improves event free survival in silent ischemia type I. Results of the Swiss Interventional Study on Silent Ischemia I (SWISS1 I). 48th Annual Scientific Session, American College of Cardiology, 1999.
6. Mahgoub MA et al. Diabetes mellitus and cardiac function. Mel Cell Biochem 1998; 80: 59-64.
7. Beth J et al. Metoprolol abolishes exercise induced left ventricular dysfunction in patients with silent ischemia. Am J Cardiol 1996; 78: 871-875.
8. Cohn PF. Silent myocardial ischemia: to treat or not to treat? Hosp Pract Off Ed 1994; 29: 107-112, 115-116.
9. Cohn PF. Rationale for the use of calcium antagonists in the treatment of silent myocardial ischemia. Clin Ther 1997; 19 (Suppl A): 74-91.
10. Pepine CJ et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994; 90: 762-768.
11. Davies RF et al. Effect of atenolol, amlodipine and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS). J Am Coil Cardiol 1995; 25: 619-625.
12. Volkov VI et al. Asymptomatic myocardial ischemia in the dynamics of anaprilin and korinfar treatment. Lik Sprava 1997; 5: 114-117.
13. Asmar R et al. Prevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertension. Am J Cardiol 1996; 77: 384-390.
14. Devereux RB et al. Measurement of left ventricular mass: methodology and expertise. J Hypertens 1997; 15: 801-809.